Donne GD, et al. - This study offers a retrospective analysis of ivabradine in pediatric patients with postural orthostatic tachycardia syndrome (POTS). Ivabradine was reported to be safe in patients younger than 18 years and, resulted in symptom improvement in 68% and phosphenes in less than 5%.